Collaborations in Research: The Common IRB Model Eric C. Mah IRB Director University of California – Davis Secretary’s Advisory Committee.

Slides:



Advertisements
Similar presentations
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Advertisements

Opening Doors: Federal Strategic Plan to Prevent and End Homelessness
Research Administration Capacity Building in an Established Institution Presenter: M.M.Aboud, MD Director of Research and Publications, MUHAS.
Back to the Drawing Board Summary of the work of the Human Services Redesign Committee from May 2012 forward.
Restructuring the Cancer Programs and Task Force Workgroups.
All you always wanted to know about Assurances Office of Research Protections (ORP) U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick,
VISN 20 Multi-Site IRB. VISN 20 Institutional Review Board Who we are: VISN 20 includes the states of Alaska, Washington, Oregon, most of the state of.
March 29, 2012 Improving Health Outcomes for Children in Foster Care: the Role of Electronic Information Exchange.
Conflict of Interest: Dartmouth College. Why do we care about it ? Conflict of Interest in Research : Unbiased research: design, conduct, reporting Maintain.
KEYS TO SUCCESS NCURA Region IV Spring Meeting April 27 – 30, 2014 © 2014 National Council of University Research Administrators National Council of University.
Multisite Human Subjects Research CUNY HRPP Coordinator Training October 19, 2012.
Knowing What Works in Health Care : A Roadmap for the Nation Alliance for Health Reform April 4, 2008 Wilhelmine Miller, MS, PhD GWU SPHHS.
ANPRM Single IRB Review mandated for multi-site domestic research P. Pearl O’Rourke, M.D. Partners Health Care.
University of Houston Health Science Center Initiative.
Philadelphia Allies Against Asthma Michael Schaffer, Coalition Co-Chair.
Introduction to Environmental Management Systems (EMS) Environmental Health & Safety Environmental Protection Program
Grant Review & Analysis Office Heather Offhaus, Director 11/1/2011.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
October 19, 2010 Steven Hirschfeld, MD, PhD Julia Slutsman, PhD
United States-Canada Regulatory Cooperation Council United States-Canada Regulatory Cooperation Council January 30, 2012 Washington D.C
Copyright © 2013 Quintiles Quintiles Site Management Kim Davis, SSRM June 17, 2014.
HCM/CPR/09/43508/1 – September Joint Working - Why, When and How? Graham Franklin Regional Business Director, GlaxoSmithKline XXX 10 th November.
Are IRBs Efficient, Effective, or Redundant? David C. Clark, Ph.D. Director, Research Compliance Rush University Center.
1 Mental Health Act and Mental Capacity Act. 2 Agenda 1. Mental Capacity Act – Deprivation of Liberty Safeguards 2. Modernising Mental Health Act function.
Responsible Conduct of Research (RCR) Farida Lada October 16, 2013
System Director, Oncology Service Line
THE COMMONWEALTH FUND Developing Innovative Payment Approaches: Finding the Path to High Performance Stuart Guterman Assistant Vice President and Director,
Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.
Office of Clinical Research and Innovative Care Compliance (OCRICC) What You Need To Know About Conducting Research at Froedtert Hospital Roberta Navarro,
URBAN SCHOOL LEADERSHIP AND GOVERNANCE PARTNERSHIPS, PARENTS AND PUBLIC ENGAGEMENT October 27, 2011 Presented By Ramona Reyes, Vice President, Columbus.
2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.
Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
James Norman, UK Public Sector CIO, EMC SUSTAINING UNIVERSAL HEALTHCARE: MAKING BETTER USE OF INFORMATION ‘Knowledge and data are.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
James D. Bearden, III, MD, FACP Principle Investigator Gibbs Cancer Center, Spartanburg, SC Gibbs Cancer Center Our NCCCP Journey 1.
Obtaining Administrative Efficiencies with IT Support Nick FisherBabs Vogelsang Director of Clinical ResearchDirector of Information TechnologySiteman.
The Wisconsin Network for Health Research (WiNHR): Overview. An Infrastructure for Conducting Multi-Site Clinical Research across the State of Wisconsin.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
Research Orientation to SCCA. What is the SCCA? The SCCA brings together the outstanding adult and pediatric oncology patient care services of three world-
Wisconsin IRB Consortium (WIC): a model for multi-site IRB review Nichelle Cobb, PhD Director, Health Sciences IRBs University of Wisconsin-Madison Secretary’s.
United States-Canada Regulatory Cooperation Council TBWG Fall Plenary November,
Cooperating Agency Status Presented by Horst Greczmiel Associate Director, NEPA Oversight Council on Environmental Quality Washington, DC September 14,
Transforming Clinical Practice Initiative (TCPI) An Overview Connie K
CTSA Improvements in Clinical Research Management Daniel Rosenblum CTSA Clinical Research Management Coordinator NCRR Secretary’s.
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Clinical Research Services: “The Beat Goes On” CTSI.
Multistate Research Program Roles & Responsibilities Eric Young SAAESD Meeting Corpus Christi, TX April 3-6, 2005.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
Second Annual Medical Research Summit March 25, 2002 Washington, D.C.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
IRB Presentation to the Pediatric Ethics Subcommittee of the FDA regarding “Gonadotropin Releasing Hormone (GnRH) Agonist Test in Disorders of Puberty”
Multi-site Research - Central/Single IRBs - Data sharing questions P. Pearl O’Rourke, MD Partners HealthCare October 26, 2015.
Moving forward.
Trial Innovation Network Uncovering Grand Opportunities
Clinical Research Coordinator Training Initiative
HUMAN RESEARCH PROTECTION PROGRAM or
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
2017 Health care Preparedness and Response Draft Capabilities
Multisite Human Subjects Research
Clinical and Translational Science Awards Program
Director, Risk and Compliance
Trial Funding and Engagement: The NIH Sponsored CTSA Program
IRB Harmonization 2016 Review
Office of Audit, Compliance & Privacy
Financial Conflicts of Interest in Human Subjects Research
Presentation transcript:

Collaborations in Research: The Common IRB Model Eric C. Mah IRB Director University of California – Davis Secretary’s Advisory Committee on Human Research Protections October 19, 2010

UC DAVIS UNIVERSITY OF CALIFORNIA

The Problem A bureaucratic, regulatory obstacle of double IRB review at local VA & developing HRPP at prominent, neighboring children’s hospital VA Northern California Health Care System –Local IRB with limited resources –Duplicative review for UC Davis faculty with joint appointments Northern California Shriners Hospitals for Children –Lack capacity, expertise for a local IRB –Limited resources available for commercial IRB review

VA Northern California & UC Davis Opportunities New relationship requires trust, communication Eliminate a double IRB review Save researcher, institutional resources Faster site initiation Streamline IRB review process Risks/Threats Unfamiliar VA structure, policies and bureaucracy Additional administrative burden on UC Davis Increased administrative costs for UC Davis

VA Northern California & UC Davis Opportunities Expand research, collaboration in pediatrics Support a neighbor institution Save researcher, institutional resources Faster site initiation Risks/Threats Shriners lacked a clear research compliance program –No COI review, etc. Some researchers unaffiliated with UC Davis UC Davis possibly exposed to significant liability

UC Davis’ Pathway to Success VA –Established new workflows and business processes to adapt to local policies, procedures 200+ studies avoid double IRB review –Significantly increased VA engaged research Increase in CTSC-VA engaged studies from 5 to 39+ Increased VA research funding to $32 M –Offered cutting edge research to VA patients –Increased accrual to oncology trials for UC Davis NCI-designated cancer center –Clinical research resources that would not otherwise be available for both institutions

UC Davis’ Pathway to Success Shriners Hospital –Education, conceptualization of a human research protection program –Established FWA, MOU with UC Davis UC Davis also performs COIC review, as needed –30+ studies reviewed on behalf of Shriners The UC Davis CTSC played a pivotal role in partnering with VA & Shriners, building regional capacity

UC Davis Results Increased the number of available trials between the institutions All stakeholders needs addressed through ongoing communication, open channels –Designated VA-UC Davis liaison Efficiencies identified, resources preserved –Especially true for VA, Shriners, and UC Davis researchers The rights and welfare of research subjects in no way compromised

UC Davis - Future Ongoing, shared commitment to human subjects protection Identify other institutions and entities for collaboration, expansion Creativity, open-mindedness, and willing to trust-- ensures future successes